AU2001264097A1 - 1, 2, 3, 5 -tetrahydrobenzo`c!azepin-4-one derivatives having muscarinic antagonist activity - Google Patents

1, 2, 3, 5 -tetrahydrobenzo`c!azepin-4-one derivatives having muscarinic antagonist activity

Info

Publication number
AU2001264097A1
AU2001264097A1 AU2001264097A AU6409701A AU2001264097A1 AU 2001264097 A1 AU2001264097 A1 AU 2001264097A1 AU 2001264097 A AU2001264097 A AU 2001264097A AU 6409701 A AU6409701 A AU 6409701A AU 2001264097 A1 AU2001264097 A1 AU 2001264097A1
Authority
AU
Australia
Prior art keywords
tetrahydrobenzo
azepin
derivatives
antagonist activity
muscarinic antagonist
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001264097A
Inventor
Robin Havard Davies
Paul Evans
Eric James Thomas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Muscagen Ltd
Original Assignee
Muscagen Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0014561A external-priority patent/GB0014561D0/en
Priority claimed from GB0100600A external-priority patent/GB0100600D0/en
Application filed by Muscagen Ltd filed Critical Muscagen Ltd
Publication of AU2001264097A1 publication Critical patent/AU2001264097A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
AU2001264097A 2000-06-14 2001-06-14 1, 2, 3, 5 -tetrahydrobenzo`c!azepin-4-one derivatives having muscarinic antagonist activity Abandoned AU2001264097A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0014561 2000-06-14
GB0014561A GB0014561D0 (en) 2000-06-14 2000-06-14 Therapeutic compounds
GB0100600 2001-01-09
GB0100600A GB0100600D0 (en) 2001-01-09 2001-01-09 Thereapeutic compounds
PCT/GB2001/002594 WO2002006241A1 (en) 2000-06-14 2001-06-14 1, 2, 3, 5 -tetrahydrobenzo`c!azepin-4-one derivatives having muscarinic antagonist activity

Publications (1)

Publication Number Publication Date
AU2001264097A1 true AU2001264097A1 (en) 2002-01-30

Family

ID=26244485

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001264097A Abandoned AU2001264097A1 (en) 2000-06-14 2001-06-14 1, 2, 3, 5 -tetrahydrobenzo`c!azepin-4-one derivatives having muscarinic antagonist activity

Country Status (4)

Country Link
US (1) US20030199494A1 (en)
EP (1) EP1294697A1 (en)
AU (1) AU2001264097A1 (en)
WO (1) WO2002006241A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE419236T1 (en) 2002-07-08 2009-01-15 Ranbaxy Lab Ltd 3,6-DISUBSTITUTED AZABICYCLO-3.1.0 HEXANE DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS
AU2003214520A1 (en) 2003-04-09 2004-11-01 Ranbaxy Laboratories Limited Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists
CN100436414C (en) 2003-04-11 2008-11-26 兰贝克赛实验室有限公司 Azabicyclo derivatives as muscarinic receptor antagonists
EP1904069B1 (en) 2005-07-15 2018-06-13 Albany Molecular Research, Inc. Aryl-and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
US20090221664A1 (en) 2005-10-19 2009-09-03 Abhijit Ray Pharmaceutical compositions of muscarinic receptor antagonists
ITBO20060424A1 (en) * 2006-05-31 2007-12-01 Ferrari Spa STEERING SYSTEM FOR A CAR

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07258250A (en) * 1994-03-25 1995-10-09 Yamanouchi Pharmaceut Co Ltd Ester derivative

Also Published As

Publication number Publication date
US20030199494A1 (en) 2003-10-23
WO2002006241A1 (en) 2002-01-24
EP1294697A1 (en) 2003-03-26

Similar Documents

Publication Publication Date Title
AU2001230026A1 (en) 2,4-diaminothiazole derivatives
AU2002361992A1 (en) 1,4-dihydro-1,4-diphenylpyridine derivatives
AU1949999A (en) Anti-fungal compositions with prolonged activity
IL161881A0 (en) N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives
HK1061852A1 (en) 4,5-dihydro-ih-pyrazole derivatives having cb1-antagonistic activity
ZA200003927B (en) 1,2,4,5-tetrahydro-benzo[d]jazepines.
AU7657000A (en) Toothbrush
AU2002235224A1 (en) Muscarinic antagonists
AU2905200A (en) Toothbrush
AU3736200A (en) Toothbrush
ZA200006352B (en) Compound napkin.
AU4402900A (en) Toothbrush
AU3819200A (en) 2,4-diamino-pyrimidine derivatives
AU2913800A (en) Toothbrush
AU7956700A (en) Toothbrush
AU1277101A (en) Toothbrush
AU2001263850A1 (en) Pyrimidine-sulfonamides having endothelin-antagonist activity
AU5786300A (en) Muscarinic antagonists
AU2001264097A1 (en) 1, 2, 3, 5 -tetrahydrobenzo`c!azepin-4-one derivatives having muscarinic antagonist activity
AU2673201A (en) Alpha-arylethylpiperazine derivatives as neurokinin antagonists
AU2002218400A1 (en) 3-substituted 2,7-naphthyridin-1-yl derivatives
AU4543300A (en) Sunscreen agents
AU2001231107A1 (en) Improved lactational
AU7956500A (en) Toothbrush
AU2694300A (en) Water-absorption-controlling-function knitting